Zevra Therapeutics, Inc. Finance Lease, Interest Payment on Liability
Zevra Therapeutics, Inc. (ZVRA) reported Finance Lease, Interest Payment on Liability of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2024-04-01
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for the quarter ending 2023-09-30 was $0.00.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for the quarter ending 2023-06-30 was $0.00.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for fiscal 2022 was $2.00K, a 77.78% decline from fiscal 2021.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for fiscal 2021 was $9.00K, a 60.87% decline from fiscal 2020.
- Zevra Therapeutics, Inc. finance lease, interest payment on liability for fiscal 2020 was $23.00K, a 42.50% decline from fiscal 2019.
| Period end | Finance Lease, Interest Payment on Liability 3 month | Finance Lease, Interest Payment on Liability 6 month | Finance Lease, Interest Payment on Liability 9 month | Finance Lease, Interest Payment on Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $1.00K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $1.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.00K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $1.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.00K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.00K derived: sum of 3 quarters · filed 2024-04-01 | $2.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $1.00K 10-Q · filed 2023-11-07 | $1.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.00K 10-Q · filed 2023-08-14 | $1.00K derived: sum of 3 quarters · filed 2023-08-14 | $3.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 | $1.00K derived: sum of 2 quarters · filed 2023-05-15 | $3.00K derived: sum of 3 quarters · filed 2023-05-15 | $6.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $2.00K derived: sum of 2 quarters · filed 2023-03-07 | $5.00K derived: sum of 3 quarters · filed 2023-03-07 | $9.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $5.00K derived: sum of 2 quarters · filed 2022-11-10 | $9.00K 10-Q · filed 2022-11-10 | $13.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $7.00K 10-Q · filed 2022-08-12 | $11.00K derived: sum of 3 quarters · filed 2022-08-12 | $15.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-12 | $8.00K derived: sum of 2 quarters · filed 2022-05-12 | $12.00K derived: sum of 3 quarters · filed 2022-05-12 | $19.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $8.00K derived: sum of 2 quarters · filed 2022-03-31 | $15.00K derived: sum of 3 quarters · filed 2022-03-31 | $23.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $11.00K derived: sum of 2 quarters · filed 2021-11-10 | $19.00K 10-Q · filed 2021-11-10 | $28.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $15.00K 10-Q · filed 2021-08-13 | $24.00K derived: sum of 3 quarters · filed 2021-08-13 | $33.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-14 | $17.00K derived: sum of 2 quarters · filed 2021-05-14 | $26.00K derived: sum of 3 quarters · filed 2021-05-14 | $37.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $18.00K derived: sum of 2 quarters · filed 2021-03-12 | $29.00K derived: sum of 3 quarters · filed 2021-03-12 | $40.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $20.00K derived: sum of 2 quarters · filed 2020-10-30 | $31.00K 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $22.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $11.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |